There is an abundance of information in the healthcare world, especially with new databases emerging such as those created through patient claims, electronic health records (EHRs), social media, and new customer engagement channels. Note that electronic medical records (EMRs) generally captures a patient’s specific interactions with specific healthcare activities that result in billing. EHR data is a longitudinal aggregation of patients' EMR data over time.
We are delighted to announce that Axtria will be participating in the Pharmaceutical Management Science Association’s (PMSA) 2019 Winter Symposium in Las Vegas at The Signature at MGM Grand. This year’s theme is “Innovation in Analytics via Machine Learning & AI.”
Axtria is proud to recognize that our Principal Scientist, Dr. George A. Chressanthis, has been inducted into the Indiana University of Pennsylvania (IUP) College of Humanities and Social Sciences (CHSS) Hall of Distinction. On September 28, 2018, Dr. Chressanthis and other alumni from across the CHSS were inaugural initiates in the CHSS Hall of Distinction, an honor bestowed on less than 0.1% of CHSS graduates.
This tri-blog series delves into the need, challenges, requisites and approaches to implementing an effective global segmentation & targeting (S&T) strategy. The upside of a standardized S&T strategy has been discussed in detail in the first blog of this series. This second blog focusses on the components of a global S&T strategy needed for its success and dives into some best practices for implementation.
We are excited to announce that Axtria will be participating in the Pharmaceutical Management Science Association’s (PMSA) second annual European Summit in Amsterdam at the iconic Hilton Amsterdam. This year’s theme is “Advanced Analytics Across the Changing EU Data Landscape.”
The tri-blog series delves into the need, challenges, and approaches to implementing an effective global segmentation & targeting strategy. The first part of the blog discusses the inherent challenges and why companies need a standardized approach and its benefits.
The life sciences industry is experiencing a digital transformation. Patients’ expectations have grown with the amount of health-related information available online, and almost 67% of healthcare professionals are set to become digital natives by 2020. Digital footprints are left at every stage of their journey and the Pharma industry must use all available insights to ensure relevant and contextual engagement.
The pharmaceutical marketing landscape has changed significantly due to the emergence of several types of “health systems” (e.g., ACOs, IDNs, IHNs, etc.), and the multiple physicians, clinics, and hospitals affiliated to these organizations. Most companies have well-established methodologies to calculate the potential of individual accounts but, since there are potential overlaps within different accounts, it is difficult to measure the potential at a health system level. It is this point that prompted the thought for this topic.
In addition to Axtria’s presentations and posters (discussed in our first blog on Axtria’s participation in PMSA’s 2018 Annual Conference), Axtria’s Principal, Devesh Verma, Ph.D., will be moderating a Next Generation Analytics Panel Discussion with roundtable participation. This session will take place on Tuesday, May 1, at 3:30 p.m.
In our previous PMSA blogs we talked about Axtria’s presentations in the General Sessions. In this blog, we will dive into the informative PMSA poster presentations. Axtria will be presenting 2 of the 16 posters being showcased in the poster session.